| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |